Physician profile
David Caldarella
NPI 1891799482
$349,294.17
in general payments reported to CMS, 2019-2025
15 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77K · 2020: $50K · 2021: $46K · 2022: $35K · 2023: $35K · 2024: $106K · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $102K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Travel and Lodging: $4,296 · Food and Beverage: $1,659 · Royalty Or License: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $102,037.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,415.63 |
| Travel and Lodging | $4,296.00 |
| Food and Beverage | $1,659.07 |
| Royalty Or License | $788.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $223,116.67 | 2019-2024 | |
| Fusion Orthopedics USA, LLC | $100,665.11 | 2023-2024 | |
| Nextremity Solutions INC. | $23,433.02 | 2019 | |
| Trimed, INC. | $983.03 | 2019 | |
| Smith+Nephew, INC. | $296.13 | 2021-2024 | Stravix, Grafix Pl, Pico 7 |
| Alafair Biosciences, INC. | $183.14 | 2025 | Versawrap |
| Biotissue Holdings INC. | $143.41 | 2024 | |
| Treace Medical Concepts, INC. | $130.25 | 2025 | |
| Linvatec Corporation | $124.76 | 2025 | Neospan, Biobrace 23mm |
| Restor3d, INC. | $64.61 | 2025 | |
| Trilliant Surgical LLC. | $47.94 | 2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Amgen INC. | $39.58 | 2019-2020 | |
| Polynovo North America LLC | $31.25 | 2024 | Novosorb Btm |
| Integra Lifesciences Corporation | $22.44 | 2019 | |
| Osiris Therapeutics INC. | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Caldarella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.